Development of Pharmaceutical Products from the Wastes of Processed Marine Shellfish Resources of India

"The shell (exoskeleton) waste of shellfish such as shrimps and crabs is the raw material in the extraction of chitosan, a polymer. Chitosan has several medicinal values such as reduction in cholesterol, urea and creatine in the blood. It is estimated that about 40000 tonnes of chitosan may be obtained from all chitin yielding invertebrate sources of India and a foreign exchange of 600 million US$ could be earned annually. Awareness has to be created among sea food processors to put up plants to convert shellfish wastes into chitosan. Similarly pharmaceutical industries may use chitosan in the development of new drugs. Types of training and awareness programmes to be organized for entrepreneurs, sea food processors and pharamacists are discussed in this paper.IntroductionIndia earns annually foreign exchange to the tune of 0.8 million US$ by exporting processed marine crustacean shellfish resources such as shrimps, crabs and lobsters (Figure 1) through 300 sea food processing industries. At present, only a small quantity of shell wastes (exoskeleton) generated from the above is utilized as an ingredient in fish feeds and hence much of the wastes are disposed off either as land fill or by direct dumping in sea. These wastes containing primarily chitin could be the major raw material for the production of a proteinaceous byproduct viz. chitosan, a highly valued pharmaceutically important source"